Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir

被引：26

作者：

Monini, Paolo ^{[1
]}

Sgadari, Cecilia ^{[1
]}

Grosso, Maria Gabriella ^{[1
]}

Bellino, Stefania ^{[1
]}

Di Biagio, Antonio ^{[2
]}

Toschi, Elena ^{[1
]}

Bacigalupo, Ilaria ^{[1
]}

Sabbatucci, Michela ^{[1
,3
]}

Cencioni, Giulia ^{[1
]}

Salvi, Emanuela ^{[1
]}

Leone, Patrizia ^{[1
]}

Ensoli, Barbara ^{[1
]}

机构：

[1] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy

[2] Univ Genoa, Infect Dis Clin, S Martino Hosp, Genoa, Italy

[3] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy

来源：

AIDS | 2009年 / 23卷 / 04期

关键词：

FIBROBLAST-GROWTH-FACTOR; INFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; NUDE-MICE; LESION FORMATION; SPINDLE CELLS; TAT PROTEIN; ANGIOGENESIS; ANTIBODIES; INDUCTION;

D O I：

10.1097/QAD.0b013e3283262a8d

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

HIV protease inhibitors have been shown to exert antiangiogenic and antitumor actions independently from their antiretroviral effect. Based on these studies, HIV-seronegative patients with classic Kaposi's sarcoma were treated with indinavir and followed for clinical evolution, drug pharmacokinetics and Kaposi's sarcoma biomarkers. A favorable clinical course was associated with high drug plasma levels, reduced production of basic fibroblast growth factor, lower numbers of circulating endothelial cells, and a decrease in antibody titers against human herpesvirus 8.

引用

页码：534 / 538

页数：5

共 50 条

[21] Tonsillar Kaposi sarcoma in an HIV-negative patient
Latini, Alessandra
Alei, Lavinia
Covello, Renato
Cristaudo, Antonio
Colafigli, Manuela
Dona, Maria Gabriella
Orsini, Diego
Morrone, Aldo
Pellini, Raul
Pichi, Barbara
[J]. AIDS, 2019, 33 (07) : 1263 - 1264
[22] Kaposi sarcoma of the penis in an HIV-negative patient
Aguilar Guevara, Jose Francisco
Lacarra Fernandez, Seila
Claros, Oliver Rojas
Giral Villalta, Pedro
Cebrian Lostal, Jose Luis
Resano Abarzuza, Miguel Angel
[J]. EINSTEIN-SAO PAULO, 2019, 17 (01): : eRC4504
[23] Orificial tuberculosis and Kaposi's sarcoma in an HIV-negative individual
Chen, YJ
Shieh, PP
Shen, JL
[J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (05) : 393 - 397
[24] A rare observation: Kaposi's sarcoma in HIV-negative spouses
Masala, M. V.
Montesu, M. A.
Cottoni, F.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (10) : 1355 - 1356
[25] PET/CT imaging of HIV-negative Kaposi’s sarcoma
S. Sager
B. Engin
Z. Kutlubay
S. Asa
S. G. Sager
B. Gucluer
B. Kanmaz
[J]. Irish Journal of Medical Science, 2013, 182 : 745 - 746
[26] Sirolimus monotherapy for Kaposi's sarcoma in an HIV-negative patient
Weenink, Jan J.
Groeneveld, Johannes O.
de Fijter, Carola W. H.
[J]. LANCET ONCOLOGY, 2006, 7 (10): : 875 - 876
[27] Oral Kaposi's sarcoma in a HIV-negative young patient
Lombardi, Niccolo
Varoni, Elena
Sardella, Andrea
Lodi, Giovanni
[J]. ORAL ONCOLOGY, 2020, 103
[28] Primary Kaposi's sarcoma of the penis in HIV-negative patient
Hernandez-Bel, P.
Lopez, J.
Sanchez, J. L.
Vilata, J. J.
Alegre, V.
[J]. ACTAS DERMO-SIFILIOGRAFICAS, 2008, 99 (08): : 662 - 663
[29] Exclusive penile Kaposi's sarcoma: report of an HIV-negative man successfully treated with radiotherapy
Zargari, O
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (03) : 318 - 320
[30] Myasthenia gravis developing in an HIV-negative patient with Kaposi’s sarcoma
Vittorio Mantero
Maria Mascolo
Monica Bandettini di Poggio
Claudia Caponnetto
Matteo Pardini
[J]. Neurological Sciences, 2013, 34 : 1249 - 1250

← 1 2 3 4 5 →